Edgar D. Charles

3.3k total citations · 1 hit paper
55 papers, 2.5k citations indexed

About

Edgar D. Charles is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Edgar D. Charles has authored 55 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 17 papers in Hepatology and 15 papers in Molecular Biology. Recurrent topics in Edgar D. Charles's work include Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (12 papers) and Fibroblast Growth Factor Research (10 papers). Edgar D. Charles is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (12 papers) and Fibroblast Growth Factor Research (10 papers). Edgar D. Charles collaborates with scholars based in United States, Japan and Denmark. Edgar D. Charles's co-authors include Lynn B. Dustin, Svetlana Marukian, Charles M. Rice, Yi Luo, Brent A. Neuschwander‐Tetri, Rose Christian, Sudeep Kundu, Arun J. Sanyal, Ira M. Jacobson and Giridhar Tirucherai and has published in prestigious journals such as The Lancet, Circulation and Blood.

In The Last Decade

Edgar D. Charles

55 papers receiving 2.5k citations

Hit Papers

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth ... 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
    2018 424 citations Arun J. Sanyal, Edgar D. Charles et al. profile →

Peers

Edgar D. Charles
J. Klempnauer Germany
Eric Lee United States
Marta Piqueras Spain
Rüdiger P. Laubender Germany
Lior H. Katz Israel
Denis Gallot France
Cheng‐Hwai Tzeng Taiwan
Jae Seung Lee South Korea
Rodrigo Liberal Portugal
Yoko Miyoshi Japan
J. Klempnauer Germany
Edgar D. Charles
Citations per year, relative to Edgar D. Charles Edgar D. Charles (= 1×) peers J. Klempnauer

Countries citing papers authored by Edgar D. Charles

Since Specialization
Citations

This map shows the geographic impact of Edgar D. Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar D. Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar D. Charles more than expected).

Fields of papers citing papers by Edgar D. Charles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar D. Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar D. Charles. The network helps show where Edgar D. Charles may publish in the future.

Co-authorship network of co-authors of Edgar D. Charles

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar D. Charles. A scholar is included among the top collaborators of Edgar D. Charles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar D. Charles. Edgar D. Charles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Lai Ping, Pinzhu Huang, Charlotte Costentin, et al.. (2025). Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis. Nature Immunology. 26(9). 1596–1611. 2 indexed citations
2.
Blauvelt, Andrew, Emma Guttman‐Yassky, Charles Lynde, et al.. (2024). Cendakimab in Patients With Moderate to Severe Atopic Dermatitis. JAMA Dermatology. 160(8). 856–856. 11 indexed citations
3.
Brown, Elizabeth A., Anne Minnich, Arun J. Sanyal, et al.. (2023). Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial. JHEP Reports. 5(4). 100661–100661. 29 indexed citations
4.
Loomba, Rohit, Arun J. Sanyal, Atsushi Nakajima, et al.. (2023). Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study. Clinical Gastroenterology and Hepatology. 22(1). 102–112.e9. 59 indexed citations
5.
Abdelmalek, Manal F., Arun J. Sanyal, Atsushi Nakajima, et al.. (2023). Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study. Clinical Gastroenterology and Hepatology. 22(1). 113–123.e9. 65 indexed citations
6.
Qosa, Hisham, Giovanni Cizza, Eric Lawitz, et al.. (2023). Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment. Clinical and Translational Science. 16(10). 1791–1802. 8 indexed citations
7.
8.
9.
Luo, Yi, Samir Wadhawan, Alex Greenfield, et al.. (2021). SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH. Hepatology Communications. 5(5). 760–773. 56 indexed citations
10.
Luo, Yi, Benjamin E. Decato, Edgar D. Charles, et al.. (2021). Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis. JHEP Reports. 4(1). 100392–100392. 16 indexed citations
11.
12.
Jacobson, Ira M., Fred Poordad, Roberto Firpi-Morell, et al.. (2019). Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study. Clinical and Translational Gastroenterology. 10(4). e00007–e00007. 12 indexed citations
13.
Wojcik, Genevieve L., P. Cacoub, Marcella Visentini, et al.. (2014). Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes and Immunity. 15(7). 500–505. 50 indexed citations
14.
Grönwall, Caroline, Edgar D. Charles, Lynn B. Dustin, Christoph Rader, & Gregg J. Silverman. (2014). Selection of Apoptotic Cell Specific Human Antibodies from Adult Bone Marrow. PLoS ONE. 9(4). e95999–e95999. 2 indexed citations
15.
Charles, Edgar D., Michael Orloff, & Lynn B. Dustin. (2010). A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells. Journal of Immunological Methods. 363(2). 210–220. 10 indexed citations
16.
Charles, Edgar D., et al.. (2009). Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: Rapid response to treatment with rituximab. Journal of Clinical Virology. 47(1). 69–71. 6 indexed citations
17.
Charles, Edgar D. & Lynn B. Dustin. (2009). Hepatitis C virus–induced cryoglobulinemia. Kidney International. 76(8). 818–824. 138 indexed citations
18.
Marukian, Svetlana, Christopher T. Jones, Linda Andrus, et al.. (2008). Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology. 48(6). 1843–1850. 195 indexed citations
19.
Kleinstein, Robert N., Anne Gordon, Jennifer S. Wayne, & Edgar D. Charles. (1985). 5-year followup of the effect on optometrists of continuing education about hypertension.. PubMed. 100(4). 364–8. 2 indexed citations
20.
Kleinstein, Robert N., Lara Maxwell, John Wayne, & Edgar D. Charles. (1982). A survey of the graduates of the University of Alabama School of Optometry. Screening for hypertension.. PubMed. 53(5). 379–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Klempnauer Breakdown of academic impact, for papers by Eric Lee Breakdown of academic impact, for papers by Marta Piqueras Breakdown of academic impact, for papers by Rüdiger P. Laubender Breakdown of academic impact, for papers by Lior H. Katz Breakdown of academic impact, for papers by Denis Gallot Breakdown of academic impact, for papers by Cheng‐Hwai Tzeng Breakdown of academic impact, for papers by Jae Seung Lee Breakdown of academic impact, for papers by Rodrigo Liberal Breakdown of academic impact, for papers by Yoko Miyoshi
Rankless by CCL
2026